002728 特一药业
已收盘 07-16 15:00:00
资讯
新帖
简况
特一药业最新公告:选举许荣煌为董事长并聘任高级管理人员
证券之星 · 11:39
特一药业最新公告:选举许荣煌为董事长并聘任高级管理人员
7月16日特一药业涨5.49%,兴全中证800六个月持有指数A基金重仓该股
证券之星 · 08:13
7月16日特一药业涨5.49%,兴全中证800六个月持有指数A基金重仓该股
特一药业股价下跌2.02% 临时股东大会明日召开
金融界 · 07-15 18:41
特一药业股价下跌2.02% 临时股东大会明日召开
特一药业:预计2025年1-6月每股收益盈利:0.07元至0.08元
证券之星 · 07-14 10:08
特一药业:预计2025年1-6月每股收益盈利:0.07元至0.08元
特一药业收盘上涨1.83%,滚动市盈率106.56倍,总市值45.72亿元
金融界 · 07-14 08:47
特一药业收盘上涨1.83%,滚动市盈率106.56倍,总市值45.72亿元
特一药业:选举姚如卿女士为第六届董事会职工代表董事
证券日报网 · 06-30
特一药业:选举姚如卿女士为第六届董事会职工代表董事
特一药业:公司药库防洪防汛措施完备确保药品安全
证券之星 · 06-26
特一药业:公司药库防洪防汛措施完备确保药品安全
特一药业:公司在中成药和化学药研发方面推行双向并举
证券之星 · 06-24
特一药业:公司在中成药和化学药研发方面推行双向并举
特一药业:持续进行产品的研究开发,推行中成药和化学药研发双向并举
证券之星 · 06-23
特一药业:持续进行产品的研究开发,推行中成药和化学药研发双向并举
每周股票复盘:特一药业(002728)完成股份回购支付101,185,418.4元
证券之星 · 06-14
每周股票复盘:特一药业(002728)完成股份回购支付101,185,418.4元
特一药业:截至2025年6月10日公司本次股份回购期限已届满回购方案已实施完毕
证券之星 · 06-13
特一药业:截至2025年6月10日公司本次股份回购期限已届满回购方案已实施完毕
特一药业:公司2024年度利润分配预案已经董事会、股东会审议通过并披露
证券之星 · 06-11
特一药业:公司2024年度利润分配预案已经董事会、股东会审议通过并披露
每周股票复盘:特一药业(002728)止咳宝片销售恢复明显,营销改革初显成效
证券之星 · 05-24
每周股票复盘:特一药业(002728)止咳宝片销售恢复明显,营销改革初显成效
特一药业(002728)2025年一季报简析:营收净利润同比双双增长,三费占比上升明显
证券之星 · 04-26
特一药业(002728)2025年一季报简析:营收净利润同比双双增长,三费占比上升明显
图解特一药业年报:第四季度单季净利润同比减77.61%
证券之星 · 04-25
图解特一药业年报:第四季度单季净利润同比减77.61%
特一药业(002728.SZ)发布一季度业绩,归母净利润3156.73万元,同比增长244.82%
智通财经 · 04-25
特一药业(002728.SZ)发布一季度业绩,归母净利润3156.73万元,同比增长244.82%
特一药业收盘下跌1.30%,滚动市盈率54.98倍,总市值38.87亿元
金融界 · 04-23
特一药业收盘下跌1.30%,滚动市盈率54.98倍,总市值38.87亿元
特一药业:自2025年一月份以来,止咳宝片在各个销售渠道有较好的恢复,目前销售正常
证券之星 · 03-07
特一药业:自2025年一月份以来,止咳宝片在各个销售渠道有较好的恢复,目前销售正常
特一药业:努力经营提升产品知名度和市场覆盖率
证券之星 · 03-07
特一药业:努力经营提升产品知名度和市场覆盖率
加载更多
公司概况
公司名称:
特一药业集团股份有限公司
所属行业:
医药制造业
上市日期:
2014-07-31
主营业务:
特一药业集团股份有限公司的主营业务是中成药品、化学制剂药品、化学原料药的研发、生产和销售。公司的主要产品是止咳宝片、感冒灵颗粒、血塞通分散片、银杏叶分散片、益心舒颗粒、铝碳酸镁咀嚼片、枫蓼肠胃康片、奥美拉唑肠溶胶囊、皮肤病血毒丸、小儿咳喘灵颗粒、金匮肾气片、降糖舒丸、独活寄生颗粒。
发行价格:
14.00
{"stockData":{"symbol":"002728","market":"SZ","secType":"STK","nameCN":"特一药业","latestPrice":9.22,"timestamp":1752649431000,"preClose":8.74,"halted":0,"volume":73476388,"delay":0,"changeRate":0.0549,"floatShares":376000000,"shares":513000000,"eps":0.0838,"marketStatus":"已收盘","change":0.48,"latestTime":"07-16 15:00:00","open":8.84,"high":9.61,"low":8.81,"amount":681000000,"amplitude":0.0915,"askPrice":9.23,"askSize":781,"bidPrice":9.22,"bidSize":3434,"shortable":0,"etf":0,"ttmEps":0.0838,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752715800000},"marketStatusCode":5,"adr":0,"adjPreClose":8.74,"symbolType":"stock","openAndCloseTimeList":[[1752629400000,1752636600000],[1752642000000,1752649200000]],"highLimit":9.61,"lowLimit":7.87,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":512588170,"isCdr":false,"pbRate":2.49,"roa":"--","peRate":110.023866,"roe":"1.77%","epsLYR":0.04,"committee":0.145773,"marketValue":4726000000,"turnoverRate":0.1952,"status":0,"floatMarketCap":3470000000},"requestUrl":"/m/hq/s/002728","defaultTab":"news","newsList":[{"id":"2551938140","title":"特一药业最新公告:选举许荣煌为董事长并聘任高级管理人员","url":"https://stock-news.laohu8.com/highlight/detail?id=2551938140","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551938140?lang=zh_cn&edition=full","pubTime":"2025-07-16 19:39","pubTimestamp":1752665967,"startTime":"0","endTime":"0","summary":"特一药业(002728.SZ)公告称,公司第六届董事会第一次会议选举许荣煌为董事长,任期与本届董事会任期相同。同时,会议还聘任许荣煌为总经理,陈习良为副总经理和财务总监,许紫兰为董事会秘书。此外,会议还选举了董事会各专门委员会成员,并聘任了其他高级管理人员和证券事务代表。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071600033118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","BK0201","BK0239"],"gpt_icon":0},{"id":"2551459791","title":"7月16日特一药业涨5.49%,兴全中证800六个月持有指数A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2551459791","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551459791?lang=zh_cn&edition=full","pubTime":"2025-07-16 16:13","pubTimestamp":1752653637,"startTime":"0","endTime":"0","summary":"证券之星消息,7月16日特一药业涨5.49%创60日新高,收盘报9.22元,换手率19.52%,成交量73.48万手,成交额6.81亿元。重仓特一药业的公募基金请见下表:根据2025基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为兴证全球基金的兴全中证800六个月持有指数A。兴全中证800六个月持有指数A目前规模为10.47亿元,最新净值1.1705,较上一交易日下跌0.26%,近一年上涨28.88%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071600025239.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","159800","BK0239","BK0201","000906.SH"],"gpt_icon":0},{"id":"2551910971","title":"特一药业股价下跌2.02% 临时股东大会明日召开","url":"https://stock-news.laohu8.com/highlight/detail?id=2551910971","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551910971?lang=zh_cn&edition=full","pubTime":"2025-07-16 02:41","pubTimestamp":1752604919,"startTime":"0","endTime":"0","summary":"截至2025年7月15日收盘,特一药业股价报8.74元,较前一交易日下跌0.18元,跌幅2.02%。当日成交量为48.69万手,成交额达4.27亿元。特一药业属于中药行业,公司主营业务涵盖中成药、化学药制剂等产品的研发、生产和销售。公司将于2025年7月16日召开临时股东大会,审议变更注册资本、修订公司章程、董事薪酬方案及董事会换届选举等议案。7月15日,特一药业主力资金净流入2688.42万元。风险提示:股市有风险,投资需谨慎。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/16024151721512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["002728","BK0201","BK0239"],"gpt_icon":0},{"id":"2551902107","title":"特一药业:预计2025年1-6月每股收益盈利:0.07元至0.08元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551902107","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551902107?lang=zh_cn&edition=full","pubTime":"2025-07-14 18:08","pubTimestamp":1752487699,"startTime":"0","endTime":"0","summary":"证券之星消息,特一药业发布业绩预告,预计2025年1-6月每股收益盈利:0.07元至0.08元。特一药业集团股份有限公司董事会2025 年 7 月 15 日特一药业2025年一季报显示,公司主营收入2.95亿元,同比上升79.29%;归母净利润3156.73万元,同比上升244.82%;扣非净利润3170.69万元,同比上升255.28%;负债率19.06%,投资收益18.64万元,财务费用95.6万元,毛利率64.72%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071400029355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","BK0201","BK0239"],"gpt_icon":0},{"id":"2551906768","title":"特一药业收盘上涨1.83%,滚动市盈率106.56倍,总市值45.72亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551906768","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551906768?lang=zh_cn&edition=full","pubTime":"2025-07-14 16:47","pubTimestamp":1752482870,"startTime":"0","endTime":"0","summary":"7月14日,特一药业今日收盘8.92元,上涨1.83%,滚动市盈率PE达到106.56倍,创26天以来新低,总市值45.72亿元。从行业市盈率排名来看,公司所处的中药行业市盈率平均32.19倍,行业中值27.42倍,特一药业排名第61位。资金流向方面,7月14日,特一药业主力资金净流入279.47万元,近5日总体呈流入状态,5日共流入548.47万元。最新一期业绩显示,2025年一季报,公司实现营业收入2.95亿元,同比79.29%;净利润3156.73万元,同比244.82%,销售毛利率64.72%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/14164751676485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK0201","002728"],"gpt_icon":0},{"id":"2547045018","title":"特一药业:选举姚如卿女士为第六届董事会职工代表董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2547045018","media":"证券日报网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547045018?lang=zh_cn&edition=full","pubTime":"2025-06-30 22:10","pubTimestamp":1751292600,"startTime":"0","endTime":"0","summary":"证券日报网讯6月30日晚间,特一药业发布公告称,公司于2025年6月27日召开了职工代表大会,经与会职工代表审议,一致同意选举姚如卿女士担任公司第六届董事会职工代表董事,任期三年,与公司第六届董事会任期一致。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-06-30/doc-infcwksi6214265.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-06-30/doc-infcwksi6214265.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002728","BK0201","BK0239"],"gpt_icon":0},{"id":"2546067222","title":"特一药业:公司药库防洪防汛措施完备确保药品安全","url":"https://stock-news.laohu8.com/highlight/detail?id=2546067222","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546067222?lang=zh_cn&edition=full","pubTime":"2025-06-26 15:18","pubTimestamp":1750922290,"startTime":"0","endTime":"0","summary":"证券之星消息,特一药业(002728)06月26日在投资者关系平台上答复投资者关心的问题。投资者提问:南方部分地区水势较猛,汛期贵司的药品配备是否充足?特一药业回复:您好!感谢您对公司的关注。公司的药库严格遵循GSP规范,在仓储建设时,就有防洪防汛方面的措施,包括仓库设计、应急预案等,以确保药品质量、安全及仓储设施的正常运行。此外,公司根据市场需求合理排产,保证安全库存以满足市场需求。谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062600018983.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002728","BK0201"],"gpt_icon":0},{"id":"2545287080","title":"特一药业:公司在中成药和化学药研发方面推行双向并举","url":"https://stock-news.laohu8.com/highlight/detail?id=2545287080","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545287080?lang=zh_cn&edition=full","pubTime":"2025-06-24 20:54","pubTimestamp":1750769647,"startTime":"0","endTime":"0","summary":"证券之星消息,特一药业06月23日在投资者关系平台上答复投资者关心的问题。你就没考虑过公司自己研发或收购原创创新药独角兽公司吗?我想你也不希望特一每年利润就在一两千万元人民币上徘徊是吧?谢谢特一药业回复:您好,感谢您对公司的关注!同时,公司也寻求外延式的发展,如有合适的优质标的,公司不排除考虑并购或联合经营,提升公司综合竞争力和整体抵御市场波动的能力,实现持续稳定发展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062400037050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","002728","BK0239"],"gpt_icon":0},{"id":"2545932144","title":"特一药业:持续进行产品的研究开发,推行中成药和化学药研发双向并举","url":"https://stock-news.laohu8.com/highlight/detail?id=2545932144","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545932144?lang=zh_cn&edition=full","pubTime":"2025-06-23 16:06","pubTimestamp":1750665967,"startTime":"0","endTime":"0","summary":"证券之星消息,特一药业06月23日在投资者关系平台上答复投资者关心的问题。批量生产的具体有哪些?谢谢特一药业回复:您好,感谢您对公司的关注!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062300016972.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002728","BK0201"],"gpt_icon":0},{"id":"2543651115","title":"每周股票复盘:特一药业(002728)完成股份回购支付101,185,418.4元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543651115","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543651115?lang=zh_cn&edition=full","pubTime":"2025-06-14 09:40","pubTimestamp":1749865221,"startTime":"0","endTime":"0","summary":"截至2025年6月13日收盘,特一药业报收于8.71元,较上周的8.8元下跌1.02%。本周,特一药业6月10日盘中最高价报9.09元。截至2025年6月10日,公司累计回购股份13,729,618股,占总股本的2.68%,最高价为8.03元/股,最低价为6.79元/股,支付资金总额为101,185,418.4元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061400010912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","BK0201","BK0239"],"gpt_icon":0},{"id":"2543682294","title":"特一药业:截至2025年6月10日公司本次股份回购期限已届满回购方案已实施完毕","url":"https://stock-news.laohu8.com/highlight/detail?id=2543682294","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543682294?lang=zh_cn&edition=full","pubTime":"2025-06-13 20:52","pubTimestamp":1749819137,"startTime":"0","endTime":"0","summary":"证券之星消息,特一药业(002728)06月12日在投资者关系平台上答复投资者关心的问题。投资者提问:请问贵司的回购完成了吗?为什么这么慢啊特一药业回复:您好!感谢您对公司的关注!截至2025年6月10日,公司本次股份回购期限已届满,回购方案已实施完毕。公司已累计购回公司股份1,372.96万股,支付的资金总额为人民币10,118.54万元(不含相关交易费用)。具体内容请您查阅公司披露的《关于股份回购实施完成暨股份变动的公告》(公告编号:2025-037),谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061300039179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","002728","BK0239"],"gpt_icon":0},{"id":"2542303694","title":"特一药业:公司2024年度利润分配预案已经董事会、股东会审议通过并披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2542303694","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542303694?lang=zh_cn&edition=full","pubTime":"2025-06-11 15:51","pubTimestamp":1749628267,"startTime":"0","endTime":"0","summary":"证券之星消息,特一药业(002728)06月11日在投资者关系平台上答复投资者关心的问题。投资者提问:请问今年什么时间分红特一药业回复:您好,感谢您对公司的关注!公司2024年度利润分配预案已经董事会、股东会审议通过并披露。根据相关规定,权益分派将在股东会审议通过后2个月内实施,公司届时将根据实际经营情况和资金安排计划,合理确定派息日,具体时间请关注公司后续披露的公告。谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061100020037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","002728"],"gpt_icon":0},{"id":"2537523163","title":"每周股票复盘:特一药业(002728)止咳宝片销售恢复明显,营销改革初显成效","url":"https://stock-news.laohu8.com/highlight/detail?id=2537523163","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537523163?lang=zh_cn&edition=full","pubTime":"2025-05-24 08:05","pubTimestamp":1748045119,"startTime":"0","endTime":"0","summary":"截至2025年5月23日收盘,特一药业报收于8.52元,较上周的8.61元下跌1.05%。2024年,止咳宝片销量的统计数据为2.3亿片,止咳宝片销售恢复明显。2025年一季度,止咳宝片销量达到了2.17亿片,呈现良好的恢复态势。公司中成药的最大单品为止咳宝片,该单品销售占比大,毛利率高,对公司业绩影响较大,但并未造成依赖。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052400009925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","BK0201","BK0239"],"gpt_icon":0},{"id":"2530172722","title":"特一药业(002728)2025年一季报简析:营收净利润同比双双增长,三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2530172722","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530172722?lang=zh_cn&edition=full","pubTime":"2025-04-27 06:33","pubTimestamp":1745706824,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期特一药业发布2025年一季报。截至本报告期末,公司营业总收入2.95亿元,同比上升79.29%,归母净利润3156.73万元,同比上升244.82%。本报告期特一药业三费占比上升明显,财务费用、销售费用和管理费用总和占总营收同比增幅达49.53%。持有特一药业最多的基金为兴全中证800六个月持有指数A,目前规模为10.47亿元,最新净值1.075,较上一交易日下跌0.09%,近一年上涨16.12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042700001730.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728"],"gpt_icon":0},{"id":"2530168845","title":"图解特一药业年报:第四季度单季净利润同比减77.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530168845","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530168845?lang=zh_cn&edition=full","pubTime":"2025-04-26 01:05","pubTimestamp":1745600756,"startTime":"0","endTime":"0","summary":"证券之星消息,特一药业2024年年报显示,公司主营收入6.88亿元,同比下降35.55%;归母净利润2049.5万元,同比下降91.9%;扣非净利润1855.24万元,同比下降92.55%;其中2024年第四季度,公司单季度主营收入2.32亿元,同比下降27.87%;单季度归母净利润1448.52万元,同比下降77.61%;单季度扣非净利润1614.41万元,同比下降74.41%;负债率26.49%,投资收益373.58万元,财务费用-71.63万元,毛利率43.92%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042600000434.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728"],"gpt_icon":0},{"id":"2530415896","title":"特一药业(002728.SZ)发布一季度业绩,归母净利润3156.73万元,同比增长244.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530415896","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530415896?lang=zh_cn&edition=full","pubTime":"2025-04-25 22:43","pubTimestamp":1745592217,"startTime":"0","endTime":"0","summary":"智通财经APP讯,特一药业(002728.SZ)发布2025年一季度报告,第一季度,公司实现营业收入2.95亿元,同比增长79.29%。归属于上市公司股东的净利润3156.73万元,同比增长244.82%。归属于上市公司股东的扣除非经常性损益的净利润3170.69万元,同比增长255.28%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1285535.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002728"],"gpt_icon":0},{"id":"2529522375","title":"特一药业收盘下跌1.30%,滚动市盈率54.98倍,总市值38.87亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529522375","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529522375?lang=zh_cn&edition=full","pubTime":"2025-04-23 16:53","pubTimestamp":1745398433,"startTime":"0","endTime":"0","summary":"4月23日,特一药业今日收盘7.61元,下跌1.30%,滚动市盈率PE达到54.98倍,总市值38.87亿元。从行业市盈率排名来看,公司所处的中药行业市盈率平均46.24倍,行业中值26.99倍,特一药业排名第51位。截至2024年三季报,共有1家机构持仓特一药业,其中基金1家,合计持股数333.38万股,持股市值0.27亿元。最新一期业绩显示,2024年三季报,公司实现营业收入4.56亿元,同比-38.87%;净利润600.98万元,同比-96.81%,销售毛利率38.84%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/23165349789644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0201","BK0239","002728"],"gpt_icon":0},{"id":"2517927143","title":"特一药业:自2025年一月份以来,止咳宝片在各个销售渠道有较好的恢复,目前销售正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2517927143","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517927143?lang=zh_cn&edition=full","pubTime":"2025-03-07 08:54","pubTimestamp":1741308849,"startTime":"0","endTime":"0","summary":"证券之星消息,特一药业(002728)03月06日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,一、公司往年的销售均以华南、华东为主,请问今年在其他区域是否有突破性进展。二、公司二月份止咳宝销售,预估是否已达到或超过2023年同期水平。特一药业回复:您好!感谢您对公司的关注!公司产品销售覆盖全国大部分区域,其中化学制剂药主要通过华南地区的经销商配送至全国,销售统计数据在华南。自2025年一月份以来,止咳宝片在各个销售渠道有较好的恢复,目前销售正常。谢谢!以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700007041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","BK0201","BK0239"],"gpt_icon":0},{"id":"2517041148","title":"特一药业:努力经营提升产品知名度和市场覆盖率","url":"https://stock-news.laohu8.com/highlight/detail?id=2517041148","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517041148?lang=zh_cn&edition=full","pubTime":"2025-03-07 08:51","pubTimestamp":1741308671,"startTime":"0","endTime":"0","summary":"证券之星消息,特一药业03月06日在投资者关系平台上答复投资者关心的问题。而不是一直这样打压股价 股价上涨 配合止咳宝营销 应该会更好一点特一药业回复:您好!股票的二级市场价格的影响因素众多,作为公司管理层,我们努力把公司的经营做得更好,科学推进营销组织变革步伐,同时通过品牌建设,进一步提高止咳宝片及特一系列产品的知名度和市场覆盖率,以利于公司长期稳定健康的发展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700007018.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","002728"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752672114072,"stockEarnings":[{"period":"1week","weight":0.0081},{"period":"1month","weight":0.0034},{"period":"3month","weight":0.1607},{"period":"6month","weight":0.0355},{"period":"1year","weight":0.1669},{"period":"ytd","weight":-0.0235}],"compareEarnings":[{"period":"1week","weight":0.0022},{"period":"1month","weight":0.0379},{"period":"3month","weight":0.0699},{"period":"6month","weight":0.0831},{"period":"1year","weight":0.1785},{"period":"ytd","weight":0.0457}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"特一药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"63146人(较上一季度减少7.04%)","perCapita":"5960股","listingDate":"2014-07-31","address":"广东省江门市台山市台城长兴路9、11号","registeredCapital":"51258万元","survey":" 特一药业集团股份有限公司的主营业务是中成药品、化学制剂药品、化学原料药的研发、生产和销售。公司的主要产品是止咳宝片、感冒灵颗粒、血塞通分散片、银杏叶分散片、益心舒颗粒、铝碳酸镁咀嚼片、枫蓼肠胃康片、奥美拉唑肠溶胶囊、皮肤病血毒丸、小儿咳喘灵颗粒、金匮肾气片、降糖舒丸、独活寄生颗粒。","listedPrice":14},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"特一药业(002728)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供特一药业(002728)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"特一药业,002728,特一药业股票,特一药业股票老虎,特一药业股票老虎国际,特一药业行情,特一药业股票行情,特一药业股价,特一药业股市,特一药业股票价格,特一药业股票交易,特一药业股票购买,特一药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"特一药业(002728)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供特一药业(002728)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}